白蛋白尿变化与肾脏及心血管结局风险:应考虑自然变异
基于英国临床实践研究数据链(2000-2015)的前瞻性队列,纳入212810例有基线尿白蛋白肌酐比(UACR)测量者,中位随访4年。分析显示基线UACR及3年内UACR翻倍均与晚期CKD风险显著相关,且考虑自然变异(回归均值)后关联强度加倍。
要点
- 基线UACR升高与晚期CKD风险强相关,校正回归均值后关联强度加倍。
- 3年内UACR翻倍者进展至4-5期CKD风险为稳定者的2.68倍(95%CI 2.29-3.14)。
- 未考虑UACR自然变异的标准分析可能低估其与肾脏结局的关联。
核心结论
- 基线和中期白蛋白尿增加均与晚期CKD风险显著相关,标准分析可能低估此关联。
研究设计与样本
- 基于英国临床实践研究数据链(2000-2015)的前瞻性队列,纳入212810例有基线UACR测量者,中位随访4年。
主要发现
- 随访期间5976例进展至4-5期CKD,1076例发生终末期肾病(ESRD)。
- 3年内UACR至少减半者进展至4-5期CKD的风险比为0.62(95%CI 0.50-0.77),至少翻倍者为2.68(2.29-3.14),均相对于UACR稳定者。
- 基线UACR与4-5期CKD或ESRD风险强相关,校正回归均值后关联强度加倍。
- 较短暴露窗口及心血管疾病或死亡结局的关联较弱,但校正回归均值后增强。
临床怎么用
- 临床评估UACR变化对肾脏风险的影响时,应考虑自然变异(回归均值)以避免低估关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Changes in urinary albumin-to-creatinine ratio (UACR) may affect the risk of advanced chronic kidney disease (CKD). How much the association changes after taking account for natural variation in UACR and the length of time taken to observe changes in UACR is unknown. METHODS: English Clinical Practice Research Datalink records (2000-2015) with linkage to secondary care and death certification were used to identify prospective cohorts with at least 2 measures of UACR within 1, 2, and 3 years. Adjusted Cox regression assessed the separate relevance of the baseline UACR and the UACR change to the risk of developing stages 4 to 5 CKD and end-stage renal disease (ESRD). Associations were compared before and after accounting for the effects of the natural variation in UACR (i.e., regression to the mean). RESULTS: A total of 212,810 individuals had baseline UACR measurements; 22% had a UACR ≥3.4 mg/mmol, and 3% had UACR ≥33.9 mg/mmol. During a median 4-year follow-up, 5976 developed stage 4 to 5 CKD, and 1076 developed ESRD. There were strong associations between baseline UACR and stage 4 to 5 CKD or ESRD risk, which doubled in strength after accounting for regression to the mean. Over 3 years, the hazard ratios (95% confidence intervals) for stage 4 to 5 CKD, relative to stable UACR, were 0.62 (0.50-0.77) for at least a halving of UACR and 2.68 (2.29-3.14) for at least a doubling of UACR. Associations were weaker for shorter exposure windows (and for cardiovascular disease or death), but strengthened after allowing for regression to the mean. CONCLUSION: Baseline values and subsequent medium-term increases in albuminuria are both associated with substantially increased risk of developing advanced CKD. Standard analyses, not allowing for natural variation in UACR, may underestimate these associations.
引用
- Smith M, Herrington WG, Weldegiorgis M, et al. Change in Albuminuria and Risk of Renal and Cardiovascular Outcomes: Natural Variation Should Be Taken into Account. Kidney Int Rep. 2018. PMID: 29988998. doi:10.1016/j.ekir.2018.04.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。